Skip to main content
Have a personal or library account? Click to login
Application of mesenchymal stem cells in paediatrics Cover
Open Access
|Dec 2017

References

  1. 1. Ahn S.Y., Chang Y.S., Park W.S.: Mesenchymal stem cells transplantation for neuroprotection in preterm infants with severe intraventricular hemorrhage. Korean J Pediatr 57(6):251-6,2014. doi: 10.3345/kjp.2014.57.6.251.
  2. 2. Bajek A., Olkowska J., Drewa T.: Mesenchymal stem cells as a therapeutic tool in tissue and organ regeneration. Postepy Hig Med Dosw 24;65:124-32,2011.
  3. 3. Ball L.M., et al.: Multiple infusions of mesenchymal stromal cells induce sustained remission in children with steroid-refractory, grade III-IV acute graft-versus-host disease. Br J Haematol. 163(4):501-9. 2013. doi: 10.1111/bjh.12545.
  4. 4. Barry F.P., et al.: The monoclonal antibody SH-2, raised against human mesenchymal stem cells, recognizes an epitope on endoglin (CD105). Biochem Biophys Res Commun 265(1):134-9, 1999.
  5. 5. Boruczkowski D., Korytowska-Niklas A., Bręborowicz A.: Zastosowanie komórek macierzystych w terapii chorób układu oddechowego - możliwości i nadzieje. Alergia Astma Immunologia 18 (3): 170-174, 2013.
  6. 6. Boruczkowski D., et al.: Krew pępowinowa. Część trzecia - przyszłość [Cord blood. Part three - the future]. Nowa Pediatria 3:61-65, 2011.
  7. 7. Caplan A.I.: Mesenchymal stem cells. J Orthop Res 9(5):641-50, 1991. 10.1002/jor.11000905041870029
  8. 8. Chang Y.S., et al.: Mesenchymal stem cells for bronchopulmonary dysplasia: phase 1 dose-escalation clinical trial. J Pediatr 164(5):966- 972, 2014. e6. doi: 10.1016/j.jpeds.2013.12.011.
  9. 9. Chicha L., Smith T., Guzman R.: Stem cells for brain repair in neonatal hypoxia-ischemia. Childs Nerv Syst , 30(1):37-46,2014. doi: 10.1007/s00381-013-2304-4.
  10. 10. Ciccocioppo R., et al.: Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn’s disease. Gut 60(6):788-98, 2011. doi: 10.1136/gut.2010.214841.
  11. 11. Dalal J, Gandy K, Domen J.: Role of mesenchymal stem cell therapy in Crohn’s disease. Pediatr Res 71(4 Pt 2):445-51, 2012. doi: 10.1038/pr.2011.56
  12. 12. Dominici M., et al.: Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8(4):315-7,2006.10.1080/1465324060085590516923606
  13. 13. Fang B, et al.: Cotransplantation of haploidentical mesenchymal stem cells to enhance engraftment of hematopoietic stem cells and to reduce the risk of graft failure in two children with severe aplastic anemia. Pediatr Transplant 13(4):499-502,2009. doi: 10.1111/j.1399-3046.2008.01002.x.
  14. 14. Farivar S., et al.: Neural differentiation of human umbilical cord mesenchymal stem cells by cerebrospinal fluid. Iran J Child Neurol 9(1):87-93, 2015.
  15. 15. Friedenstein A.J., et al.: Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17(4):331-40, 1974.10.1097/00007890-197404000-000014150881
  16. 16. Gentili C., Torre M., Cancedda R.: Tissue engineering approaches in skeletal pediatric disorders. Eur J Pediatr Surg 24(3):263-9, 2014. doi: 10.1055/s-0034-1382777.
  17. 17. Gortner L., et al.: Regenerative therapies in neonatology: clinical perspectives. Klin Padiatr 224(4):233-40, 2012.
  18. 18. Götherström C., et al.: Pre- and postnatal transplantation of fetal mesenchymal stem cells in osteogenesis imperfecta: a two-center experience. Stem Cells Transl Med 3(2):255-64, 2014. doi: 10.5966/sctm.2013-0090.
  19. 19. Heijnen C.J., Witt O., Wulffraat N., Kulozik A.E.: Stem cells in pediatrics: state of the art and future perspectives. Pediatr Res 71(4 Pt 2):407-9,2012. doi: 10.1038/pr.2012.1.
  20. 20. Hibi H., Yamada Y., Ueda M., Endo Y.: Alveolar cleft osteoplasty using tissue-engineered osteogenic material. Int J Oral Maxillofac Surg 35(6):551-5,2006.
  21. 21. Hu J., et al.: Long term effects of the implantation of Wharton’s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J 60(3):347-57, 2013.
  22. 22. Introna M., et al.: Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients. Biol Blood Marrow Transplant. 20(3):375-81, 2014. doi: 10.1016/j.bbmt.2013.11.033.
  23. 23. Jin J.L., et al.: Safety and efficacy of umbilical cord mesenchymal stem cell therapy in hereditary spinocerebellar ataxia. Curr Neurovasc Res 10(1):11-20,2013.10.2174/15672021380480593623151076
  24. 24. Jozwiak S., et al.: Intracerebroventricular Transplantation of Cord Blood-Derived Neural Progenitors in a Child With Severe Global Brain Ischemic Injury. Cell Medicine 1,2:71-80,2010.
  25. 25. Jung J.W., et al.: Familial occurrence of pulmonary embolism after intravenous, adipose tissue-derived stem cell therapy. Yonsei Med J 54(5):1293-6, 2013. doi: 10.3349/ymj.2013.54.5.1293.
  26. 26. Krenska A., et al.: The use of mesenchymal stem cells in therapy of steroid-resistance chronic refractory graft-versus-host disease after hematopoietic stem cell transplantation. Medical and Biological Sciences 28, 3, 57-61, 2014.10.12775/MBS.2014.026
  27. 27. Kurtzberg J., et al.: Allogeneic human mesenchymal stem cell therapy (remestemcel-L, Prochymal) as a rescue agent for severe refractory acute graft-versus-host disease in pediatric patients. Biol Blood Marrow Transplant 20(2):229-35, 2014. doi: 10.1016/j. bbmt.2013.11.001.
  28. 28. Lacis A., Erglis A.: Intramyocardial administration of autologous bone marrow mononuclear cells in a critically ill child with dilated cardiomyopathy. Cardiol Young 21(1):110-2, 2011. doi: 10.1017/ S1047951110001435.
  29. 29. Le Blanc K., et al.: Developmental Committee of the European Group for Blood and Marrow Transplantation. Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study. Lancet 10;371:1579-86, 2008. doi: 10.1016/ S0140-6736(08)60690-X.
  30. 30. Liang J., et al.: Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis 69(8):1423-9, 2010. doi: 10.1136/ard.2009.123463.
  31. 31. Lv Y.T., et al.: Transplantation of human cord blood mononuclear cells and umbilical cord-derived mesenchymal stem cells in autism. J Transl Med 27;11:196, 2013. doi: 10.1186/1479-5876-11-196.
  32. 32. Mei S.H., et al.: Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 15;182(8):1047-57, 2010. doi: 10.1164/ rccm.201001-0010OC.
  33. 33. Norambuena G.A., Khoury M., Jorgensen C.: Mesenchymal stem cells in osteoarticular pediatric diseases: an update. Pediatr Res 71 (4Pt2):452-8, 2012. doi: 10.1038/pr.2011.68.
  34. 34. Pal R., et al.: Ex vivo-expanded autologous bone marrow-derived mesenchymal stromal cells in human spinal cord injury/paraplegia: a pilot clinical study. Cytotherapy 11(7):897-911, 2009. doi: 10.3109/14653240903253857.
  35. 35. Pesmatzoglou M., Dimit r iou H., St iakaki E .: Could mesenchymal st romal cel ls have a role in chi ldhood autoimmune diseases? Immunol Invest 42(7):639-56. 2013. doi: 10.3109/08820139.2013.822393.
  36. 36. Prasad V.K., et al.: Efficacy and safety of ex vivo cultured adult human mesenchymal stem cells (Prochymal™) in pediatric patients with severe refractory acute graft-versus-host disease in a compassionate use study. Biol Blood Marrow Transplant 17(4):534-41, 2011. doi: 10.1016/j.bbmt.2010.04.014.
  37. 37. Selem S.M., Kaushal S., Hare J.M.: Stem cell therapy for pediatric dilated cardiomyopathy. Curr Cardiol Rep 15(6):369, 2013. doi: 10.1007/s11886-013-0369-z.
  38. 38. Sun L., et al.: Umbilical cord mesenchymal stem cell transplantation in severe and refractory systemic lupus erythematosus. Arthritis Rheum 62(8):2467-75, 2010. doi: 10.1002/art.27548.
  39. 39. Sun Y., Zhang F.S., Zhang Z.Y.: Immunoregulatory effect of bone marrow mesenchymal stem cells on regulatory T cells in patients with systemic lupus erythematosis. Zhonghua Nei Ke Za Zhi 46(12):1018-21, 2007.
  40. 40. Tyndall A.: Application of autologous stem cell transplantation in various adult and pediatric rheumatic diseases. Pediatr Res 71(4 Pt 2):433-8, 2012. doi: 10.1038/pr.2011.66.
  41. 41. van Velthoven C.T., Gonzalez F., Vexler Z.S., Ferriero D.M.: Stem cells for neonatal stroke- the future is here. Front Cell Neurosci 25;8:207, 2014. doi: 10.3389/fncel.2014.00207.
  42. 42. Vassena R., et al.: ESHRE special interest group Stem Cells. Stem cells in reproductive medicine: ready for the patient? Hum Reprod 30(9):2014-21, 2015. doi: 10.1093/humrep/dev181.
  43. 43. Wakitani S., et al.: Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: two case reports. Cell Transplant 13(5):595-600, 2004.10.3727/00000000478398374715565871
  44. 44. Wernicke C.M., et al.: Mesenchymal stromal cells for treatment of steroid-refractory GvHD: a review of the literature and two pediatric cases. Int Arch Med 15;4(1):27, 2011.doi:10.1186/1755-7682-4-27.
  45. 45. Wong R.S.Y., Mesenchymal stem cells: Angels or demons? J of Biomed Biotechnol 459510, 2011. doi.org/10.1155/2011/459510 10.1155/2011/459510314278621822372
  46. 46. www.clinicaltrials.gov
  47. 47. Zheng J.C., Tong Z.: Exciting progresses in stem cell and neural stem cell research. Curr Mol Med 13(9):1409-11, 2013.
DOI: https://doi.org/10.1515/cipms-2017-0022 | Journal eISSN: 2300-6676 | Journal ISSN: 2084-980X
Language: English
Page range: 123 - 128
Submitted on: Jul 3, 2017
Accepted on: Oct 10, 2017
Published online: Dec 29, 2017
Published in print: Sep 26, 2017
Published by: Sciendo
In partnership with: Paradigm Publishing Services

© 2017 Ewelina Wawryk-Gawda, Beata Wojcik, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.